Insulet | PODD - SCHULD





SCHULD Veränderung Datum
Abbott USD 34.05B 20.19B 2026-03
Align Technology USD 116.04M 1.6M 2026-03
AtriCure USD 71.78M 1.6M 2026-03
Baxter International USD 9.69B 93M 2026-03
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Boston Scientific USD 11.03B 407M 2026-03
Cardinal Health USD 8.89B 30M 2026-06
Cooper Companies USD 2.46B 39.5M 2026-03
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Globus Medical USD 115.22M 3.43M 2026-03
ICU Medical USD 1.23B 94.6M 2026-06
Inogen USD 0 0 2022-06
Insulet USD 948.4M 300K 2026-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
J&J USD 54.99B 7.05B 2026-03
Medtronic USD 28.15B 192M 2026-06
Merit Medical Systems USD 821.56M 9K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 132.16M 2026-06
Teleflex USD 2.69B 39.95M 2026-03
West Pharmaceutical Services USD 202.8M 0 2026-03
Zimmer Biomet Holdings USD 7.48B 8M 2026-06